Literature DB >> 16469089

A case of diffuse plane normolipemic xanthomatosis associated with pancytopenia and monoclonal gammopathy.

Kazuhiro Kourou1, Yasushi Suga, Shigenori Muramatsu, Hitoshi Yaguchi, Hideoki Ogawa.   

Abstract

We report a case of diffuse plane normolipemic xanthomatosis (DPNX) which showed poorly demarcated, uncommon, yellow macules symmetrically distributed on the nape, axillae and inguinal folds accompanied by severe, persistent itching. Histopathological and ultrastructural studies of skin biopsy specimens revealed the existence of some foamy cells and the deposition of neutral fat in the upper papillary dermis. Laboratory investigations and bone marrow aspirate smears showed that our patient had myelodysplastic syndrome (MDS) associated with pancytopenia and monoclonal gammopathy of undetermined significance. Because our patient had neither a malignant hematological disorder nor a severe systemic disease, monoclonal gammopathy might explain the pathogenesis of DPNX in the present case.

Entities:  

Mesh:

Year:  2006        PMID: 16469089     DOI: 10.1111/j.1346-8138.2006.00013.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  Necrobiotic Xanthogranuloma Coexists with Diffuse Normolipidemic Plane Xanthoma and Multiple Myeloma.

Authors:  Joon Goon Kim; Hye Ri Kim; Moon Hyung You; Dong Hoon Shin; Jong Soo Choi; Young Kyung Bae
Journal:  Ann Dermatol       Date:  2019-12-27       Impact factor: 1.444

2.  Diffuse plane xanthomatosis in a patient with Budd-Chiari syndrome and monoclonal gammopathy.

Authors:  Mukadder Koçak; Hatice Keleş; Fahri Yakaryilmaz; Onder Bozdoğan; Sefa Güliter
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

3.  Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy.

Authors:  R Szalat; J Pirault; J-P Fermand; A Carrié; F Saint-Charles; M Olivier; P Robillard; E Frisdal; E F Villard; P Cathébras; E Bruckert; M John Chapman; P Giral; M Guerin; P Lesnik; W Le Goff
Journal:  J Intern Med       Date:  2014-02-10       Impact factor: 8.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.